US-Listed Pharmaceutical Preparations — Net Income Percentiles, FY 2025
Population: 485 US-listed companies (SIC 2834), fiscal year 2025; fiscal year ends 2025-06-30 to 2026-05-31.
Cite as: FACTANKER, https://factanker.com/industries/sic-2834/net-income/2025
Fiscal year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · latest
| 10th percentile | $-208.4M |
|---|---|
| 25th percentile | $-83.5M |
| Median | $-23.7M |
| 75th percentile | $-4.7M |
| 90th percentile | $43.7M |
| Mean | $-16.3B |
| Minimum | $-8.0T |
| Maximum | $26.8B |
Methodology & sources
Net Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2025 = fiscal years ending 2025-06-01 to 2026-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-07.
Net Income as filed, one fiscal year per company; percentiles computed in the database via percentile_cont, never by a model. Fiscal year 2025 = fiscal years ending 2025-06-01 to 2026-05-31 (majority-overlap rule; June-ending fiscal years count toward the ending calendar year).
Source: SEC EDGAR filings (public domain). Data: FACTANKER registry, precomputed 2026-09-07.
Evidence samples
Latest Net Income percentiles (live) · All Pharmaceutical Preparations benchmarks · All industries